Macroaxis: Personalized Investing
Simple Personalized Investing

BAX COV BDX BCR Farming Utilities Synthetics Recycling 
Benchmark SP 500  1,650   0.91  Index Moved Down -0.06% ...


Processing
Collecting data for LMNX

Luminex quote and profile

 
 Companies |  Insiders  | Dashboard  
     
19.11
  
STOCK
0.15  Macroaxis: 0.79 Up   0.79%  
Year To Date
15.5825.79
Last 1 Month(s)
15.5119.11
Trading Day 
18.7519.2
May 25 2013 

Diversification Suggestion

Use Luminex to enhance returns of your portfolios. The stock experiences moderate upward volatility
Analyze Luminex Trend or Check current 30 days Luminex correlation with market (S&P 500)
1 Month Beta 2.39  
Highest Price:  
Lowest Price:  
19.11  
15.51  
May 24 2013 
May 01 2013 
As market goes up, the company is expected to significantly outperform it. However, if the market returns are negative, Luminex will likely underperform.
Luminex Corporation Large BetaLuminex Beta Legend
LMNX United States Nasdaq
Luminex Corporation
Healthcare
Medical Instruments and Supplies
Benchmark S&P 500
http://www.luminexcorp.com
Contact Number: 512. 219. 8020
Currency: USD - US Dollar
Traded on NASDAQ
    
Current Valuation706.3 M
Shares Outstanding41.59 M
Number of Shares Shorted2.14 M
Revenue207.05 M
 United States Nasdaq   0.97 % Macroaxis: 0.97 Moved Up  
 
 thisGreen LMNX LMNX agains markets  0.79 % Macroaxis: 0.79 Moved Up  
 
 United States Russel   0.00 % No Change  
 United States SP 500   0.06 % Macroaxis: 0.06 Moved Down  
 
 United States NYSE   0.25 % Macroaxis: 0.25 Moved Down  
 
Compare to Competition Get Alpha   Get Advice

Luminex Leadership

Patrick Balthrop President CEO, Director, MBA
Patrick Sr CEO and President Director, Member of Executive Committee and Member of Strategy and Devel. Committee
G Loewenbaum Chairman of the Board
Timothy Dehne Vice President - Systems Research and Development

Luminex Price and Market Media

The median price of Luminex for the period between Thu, Apr 25, 2013 and Sat, May 25, 2013 is 17.96 with a coefficient of variation of 5.71. The daily time series for the period is distributed with a sample standard deviation of 1.01, arithmetic mean of 17.67, and mean deviation of 0.89. The Stock received substential amount of media coverage during this period.
Luminex         SP 500
Price Growth (%)
 
1
Luminex Corporation CEO Discusses Q1 2013 Results Earnings C...04/30/2013Macroaxis: Seeking Alpha News
2
Luminex Beats 1Q Earnings Est. Analyst Blog NASDAQ.com05/02/2013Macroaxis: News
3
Top Buys by Directors Loewenbaum II 421.6K Bet on LMNX05/07/2013Macroaxis: Forbes News
4
Top Insider Purchases ADNC HLF JPM LMNX SPW NTS05/09/2013Macroaxis: News
5
Top Insider Purchases HL OPK LMNX SKUL WES X05/16/2013Macroaxis: News
6
Luminex To Present At UBS Global Healthcare Conference Webca...05/22/2013Macroaxis: News

Luminex Summary

Luminex Corporation [LMNX] is traded on NASDAQ in USA. It is located in Austin, TX and employs 687 people. The company currently falls under 'Small-Cap' category with current market capitalization of 765.62 M. Luminex Corporation conducts business under Healthcare sector and is part of Medical Instruments and Supplies industry. This company has 41.59 M outstanding shares of which 2.14 M shares are now shorted by private and institutional investors with about 17.9 trading days to cover.
Luminex Corporationration engages in the development, manufacture, and sale of proprietary biological testing technologies and solutions for the life sciences and diagnostic industries. more
Past Market
Over 30
Days
11
Out Of
100
 
Chance of
Less
Than
%
 
Follow Luminex with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker
Add To Reader
 
Add Luminex to your reader
 

Luminex Research Report

Luminex vs. Baxter

Correlation analysis and fundamentals comparison between Luminex and Baxter International

Luminex Executives

Harriss Currie CFO, Sr. VP of Fin., Principal Accounting Officer and Treasurer, MBA

Luminex Directors

Fred Goad Independent Director
Edward Ogunro Independent Director, Ph.D
Robert Cresci Independent Director, MBA
Kevin McNamara Independent Director, MBA
Jay Johnston Independent Director, MBA

Luminex Management

Jeremy Bridge-Cook Sr. VP of RandD
Russell Bradley Sr. VP of Bus. Devel. and Strategic Planning

Luminex Fundamentals

Shares Outstanding vs Retained Earnings
Working Capital vs Revenue
Shares Outstanding vs Operating Margin
Current Liabilities vs Revenue

Luminex vs Competition

Luminex vs. Baxter International Inc
Luminex vs. Covidien plc
Luminex vs. Becton Dickinson and Company
Luminex vs. CR Bard Inc
Luminex vs. CareFusion Corporation
Luminex vs. DENTSPLY International Inc
Luminex vs. The Cooper Companies Inc
Luminex vs. Mindray Medical International Limited
Luminex vs. Teleflex Incorporated
Luminex vs. West Pharmaceutical Services Inc

Luminex May 25 2013 Opportunity Range

Downside Deviation3.54
Information Ratio0.1461
Maximum Drawdown11.75
Value At Risk(2.97)
Potential Upside6.0

 
Analytics
Risk Adjusted Returns Landscape
Live Efficient Frontier
Market Correlation Analysis
Watchlist Analysis
Financial Content
Portfolio Estimation and Projections
Portfolio Theme Builder
 
 
Research Modules
Equities Backtesting Analysis
Instant Retirement Optimizer
Cross-portfolio RSS and Mobile Access
Company, fund, and ETF Directory
Financial Advisor Directory
Insider and Manager Directory
Wealth Management
 Gadgets, Widgets, and Apps          
  
 
Services And Technology
Frequently Asked Questions
Quick Product Tour
Product Technology Overview
Solution Methodology
Plans and Pricing
 
Free Investor Tools
World Market Correlations
Instant Equity Comparator
Watchlist Analysis
Position Suggestions
Equity Alpha Analysis
 
About Us
About Macroaxis
Contact Us
Product Terms Of Use
Service Privacy Policy
Advertising Opportunities
Content

Thanks for checking out Macroaxis

Tell us what you like and what you don't like. We promise we'll not only listen but write you back

Contact Us
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide. Please fill out our quick survey to help us provide your with a better service and user experience

Fill Out Quick Survey
Most of the functionality on our site is free to use. However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory

Go Premium